The American Journal of Managed Care

New First-in-Class ITP Therapy May Transform Clinical Practice: David Kuter, MD, DPhil

Rilzabrutinib (Wayrilz; Sanofi) may improve immune thrombocytopenia (ITP) outcomes, enable early intervention, and enhance patient quality of life.
MassDevice

Medtronic launches full U.S. distribution of Neuroguard IEP carotid stent system

Medtronic today announced the full U.S. rollout of the Neuroguard IEP system, a carotid stent and embolic protection device.

Relmada Therapeutics Appoints Distinguished Urologic Oncologist, Max Kates, MD, to the Clinical Advisory Board to Support Development of NDV-01

Dr. Kates’ experience as chair of the landmark Phase 3 BRIDGE bladder cancer trial and dedication to patient care will be invaluable to the ...

NeuroOne Medical Technologies Corporation (NMTC) Virtual Investor Webinar Call Transcript

Good day, ladies and gentlemen, and welcome to the NeuroOne Medical Technologies Corporation Virtual Webinar. Today's call will be conducted by the company's Chief Executive Officer, Dave Rosa, and ...